Clinical trial
Optimal Frequency of Total Body Water Measurements by Bioelectrical Impedance Analysis to Prevent Intradialytic Hypotension
NCT06279156 is registered in ClinicalTrials.gov with Thammasat University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Frequency of Total Body Water Measurements by Bioelectrical Impedance Analysis to Prevent Intradialytic Hypotension
- Lead sponsor
- Thammasat University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2022
- Completion date
- February 28, 2023
- Enrollment
- 94 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease on dialysis, intradialytic hypotension